These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 15533297)

  • 1. Efficacy of Trypan: a diminazene based drug as antileishmanial agent.
    Macharia JC; Bourdichon AJ; Gicheru MM
    Acta Trop; 2004; 92(3):267-72. PubMed ID: 15533297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity, toxicity and analysis of resistance of essential oil from Chenopodium ambrosioides after intraperitoneal, oral and intralesional administration in BALB/c mice infected with Leishmania amazonensis: a preliminary study.
    Monzote L; Montalvo AM; Scull R; Miranda M; Abreu J
    Biomed Pharmacother; 2007; 61(2-3):148-53. PubMed ID: 17254746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A trial of immunotherapy against Leishmania amazonensis infection in vitro and in vivo with Z-100, a polysaccharide obtained from Mycobacterium tuberculosis, alone or combined with meglumine antimoniate.
    Barroso PA; Marco JD; Calvopina M; Kato H; Korenaga M; Hashiguchi Y
    J Antimicrob Chemother; 2007 Jun; 59(6):1123-9. PubMed ID: 17439977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tamoxifen as a potential antileishmanial agent: efficacy in the treatment of Leishmania braziliensis and Leishmania chagasi infections.
    Miguel DC; Zauli-Nascimento RC; Yokoyama-Yasunaka JK; Katz S; Barbiéri CL; Uliana SR
    J Antimicrob Chemother; 2009 Feb; 63(2):365-8. PubMed ID: 19095684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro and in-vivo studies on a topical formulation of sitamaquine dihydrochloride for cutaneous leishmaniasis.
    Garnier T; Brown MB; Lawrence MJ; Croft SL
    J Pharm Pharmacol; 2006 Aug; 58(8):1043-54. PubMed ID: 16872550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory activity of limonene against Leishmania parasites in vitro and in vivo.
    Arruda DC; Miguel DC; Yokoyama-Yasunaka JK; Katzin AM; Uliana SR
    Biomed Pharmacother; 2009 Nov; 63(9):643-9. PubMed ID: 19321295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of physalins purified from Physalis angulata in in vitro and in vivo models of cutaneous leishmaniasis.
    Guimarães ET; Lima MS; Santos LA; Ribeiro IM; Tomassini TB; Ribeiro dos Santos R; dos Santos WL; Soares MB
    J Antimicrob Chemother; 2009 Jul; 64(1):84-7. PubMed ID: 19454526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo studies on the antileishmanial activity of buparvaquone and its prodrugs.
    Garnier T; Mäntylä A; Järvinen T; Lawrence J; Brown M; Croft S
    J Antimicrob Chemother; 2007 Oct; 60(4):802-10. PubMed ID: 17715126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (Aminosidine) and gentamicin.
    Grogl M; Schuster BG; Ellis WY; Berman JD
    J Parasitol; 1999 Apr; 85(2):354-9. PubMed ID: 10219319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of imidocarb and levamisole on the experimental infection of BALB/c mice by Leishmania (Leishmania) amazonensis.
    Rodrigues FH; Afonso-Cardoso SR; Gomes MA; Beletti ME; Rocha A; Guimarães AH; Candeloro I; de Souza MA
    Vet Parasitol; 2006 Jun; 139(1-3):37-46. PubMed ID: 16647821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of the intralesional treatment with Chenopodium ambrosioides in the murine infection by Leishmania amazonensis.
    Patrício FJ; Costa GC; Pereira PV; Aragão-Filho WC; Sousa SM; Frazão JB; Pereira WS; Maciel MC; Silva LA; Amaral FM; Rebêlo JM; Guerra RN; Ribeiro MN; Nascimento FR
    J Ethnopharmacol; 2008 Jan; 115(2):313-9. PubMed ID: 18035510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leishmania major: in vitro and in vivo anti-leishmanial effect of cantharidin.
    Ghaffarifar F
    Exp Parasitol; 2010 Oct; 126(2):126-9. PubMed ID: 20435039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic treatment of BALB/c mice with cyclosporine A and its analog B-5-49 enhances resistance to Leishmania major.
    Behforouz NC; Wenger CD; Mathison BA
    J Immunol; 1986 Apr; 136(8):3067-75. PubMed ID: 3958489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leishmanicidal activity of Himatanthus sucuuba latex against Leishmania amazonensis.
    Soares DC; Andrade AL; Delorenzi JC; Silva JR; Freire-de-Lima L; Falcão CA; Pinto AC; Rossi-Bergmann B; Saraiva EM
    Parasitol Int; 2010 Jun; 59(2):173-7. PubMed ID: 20096374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of chalcone analogues with increased antileishmanial activity.
    Boeck P; Bandeira Falcão CA; Leal PC; Yunes RA; Filho VC; Torres-Santos EC; Rossi-Bergmann B
    Bioorg Med Chem; 2006 Mar; 14(5):1538-45. PubMed ID: 16386424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo activity of perifosine against Leishmania amazonensis.
    Cabrera-Serra MG; Valladares B; Piñero JE
    Acta Trop; 2008 Oct; 108(1):20-5. PubMed ID: 18801328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulatory effect of Canova medication on experimental Leishmania amazonensis infection.
    Pereira WK; Lonardoni MV; Grespan R; Caparroz-Assef SM; Cuman RK; Bersani-Amado CA
    J Infect; 2005 Aug; 51(2):157-64. PubMed ID: 16038768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection and phenotype characterisation of sitamaquine-resistant promastigotes of Leishmania donovani.
    Bories C; Cojean S; Huteau F; Loiseau PM
    Biomed Pharmacother; 2008 Mar; 62(3):164-7. PubMed ID: 18249083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colloidal, in vitro and in vivo anti-leishmanial properties of transfersomes containing paromomycin sulfate in susceptible BALB/c mice.
    Bavarsad N; Fazly Bazzaz BS; Khamesipour A; Jaafari MR
    Acta Trop; 2012 Oct; 124(1):33-41. PubMed ID: 22750480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, in vitro evaluation, and antileishmanial activity of water-soluble prodrugs of buparvaquone.
    Mäntylä A; Garnier T; Rautio J; Nevalainen T; Vepsälainen J; Koskinen A; Croft SL; Järvinen T
    J Med Chem; 2004 Jan; 47(1):188-95. PubMed ID: 14695832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.